Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to $41.6 million.

  • Anaptysbio's Operating Expenses fell 2114.3% to $41.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $198.1 million, marking a year-over-year decrease of 314.98%. This contributed to the annual value of $206.2 million for FY2024, which is 1358.22% up from last year.
  • According to the latest figures from Q3 2025, Anaptysbio's Operating Expenses is $41.6 million, which was down 2114.3% from $48.4 million recorded in Q2 2025.
  • Anaptysbio's 5-year Operating Expenses high stood at $55.3 million for Q1 2025, and its period low was $27.7 million during Q3 2021.
  • Over the past 5 years, Anaptysbio's median Operating Expenses value was $41.6 million (recorded in 2025), while the average stood at $41.0 million.
  • In the last 5 years, Anaptysbio's Operating Expenses skyrocketed by 5600.5% in 2023 and then crashed by 2114.3% in 2025.
  • Quarter analysis of 5 years shows Anaptysbio's Operating Expenses stood at $32.2 million in 2021, then increased by 1.91% to $32.8 million in 2022, then soared by 56.01% to $51.1 million in 2023, then rose by 3.21% to $52.8 million in 2024, then dropped by 21.16% to $41.6 million in 2025.
  • Its last three reported values are $41.6 million in Q3 2025, $48.4 million for Q2 2025, and $55.3 million during Q1 2025.